Li Bing, Wang Yong, Owens Charles R, Banaee Touka, Chu Charleen T, Jabbari Kayvon, Lee Anna D, Khatter Neil J, Palestine Alan G, Su An-Jey A, Huang Christene A, Washington Kia M
Division of Plastic Surgery, Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
Department of Ophthalmology and Visual Sciences, University of Texas Medical Branch, Galveston, TX, United States.
Front Immunol. 2025 Jan 29;16:1475055. doi: 10.3389/fimmu.2025.1475055. eCollection 2025.
Whole Eye Transplantation (WET) offers potential for vision restoration but is hindered by the complex challenge of immune rejection. Understanding and closely monitoring these immunological responses is crucial for advancing WET. This study delves into the timeline and nature of immune responses in a rodent model of WET without immunosuppression, aiming to elucidate a detailed picture of the immune landscape post-transplantation and establish innovative diagnostic and monitoring methods.
We employed a multi-faceted approach to analyze immune responses post-WET, including assessments of gross changes in corneal transparency, thickness, and skin condition. Histopathological examinations of both ocular and surrounding skin tissues provided insights into cellular changes, complemented by ocular RT-qPCR for molecular analysis. Serological analysis was employed to quantify cytokines, chemokines, and donor-specific antibodies, aiming to identify potential biomarkers correlating with WET rejection and to validate the presence of antibody-mediated rejection. These methodologies collectively contribute to the development of non-invasive diagnostic and monitoring strategies for WET.
Our study revealed a rapid and acute immune response following WET, characterized by an early innate immune response dominated by complement involvement, and infiltration of neutrophils and monocytes by post-operative day (POD) 2. This was succeeded by an acute T-cell-mediated immune reaction, predominantly involving T helper 1 (Th1) cells and cytotoxic T lymphocytes (CTLs). The presence of donor specific antibody (DSA) and indications of pyroptosis in the early phases of rejection were observed. Notably, the early elevation of serum CXCL10 by POD4, coupled with ocular CD3+ cell infiltration, emerged as a potential early biomarker for WET rejection. Additionally, corneal transparency grading proved effective as a non-invasive monitoring tool.
This study offers a first-time comprehensive exploration of immune responses in WET, unveiling rapid and complex rejection mechanisms. The identification of early biomarkers and the development of non-invasive monitoring techniques significantly advance our understanding of WET rejection. Additionally, these findings establish an essential baseline for future research in this evolving field.
全眼移植(WET)为视力恢复提供了可能,但受到免疫排斥这一复杂挑战的阻碍。了解并密切监测这些免疫反应对于推进全眼移植至关重要。本研究深入探究了未进行免疫抑制的全眼移植啮齿动物模型中免疫反应的时间线和性质,旨在阐明移植后免疫状况的详细情况,并建立创新的诊断和监测方法。
我们采用多方面的方法来分析全眼移植后的免疫反应,包括评估角膜透明度、厚度和皮肤状况的总体变化。对眼部和周围皮肤组织进行组织病理学检查,以了解细胞变化,并通过眼部实时定量聚合酶链反应(RT-qPCR)进行分子分析。采用血清学分析来量化细胞因子、趋化因子和供体特异性抗体,旨在识别与全眼移植排斥相关的潜在生物标志物,并验证抗体介导的排斥反应的存在。这些方法共同促进了全眼移植非侵入性诊断和监测策略的发展。
我们的研究显示,全眼移植后会出现快速而急性的免疫反应,其特征是早期固有免疫反应以补体参与为主,术后第2天(POD2)中性粒细胞和单核细胞浸润。随后是急性T细胞介导的免疫反应,主要涉及辅助性T细胞1(Th1)和细胞毒性T淋巴细胞(CTL)。在排斥反应的早期阶段观察到了供体特异性抗体(DSA)的存在和细胞焦亡的迹象。值得注意的是,术后第4天血清CXCL10的早期升高,以及眼部CD3+细胞浸润,成为全眼移植排斥的潜在早期生物标志物。此外,角膜透明度分级被证明是一种有效的非侵入性监测工具。
本研究首次全面探索了全眼移植中的免疫反应,揭示了快速而复杂的排斥机制。早期生物标志物的识别和非侵入性监测技术的发展显著推进了我们对全眼移植排斥的理解。此外,这些发现为这一不断发展的领域的未来研究奠定了重要基础。